Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoxi Ling

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|September 29, 2020
Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma CellsJemianne B Jia, Xiaoxi Ling, Minzhi Xing, et al.
Photodiagnosis and Photodynamic Therapy|September 22, 2018
Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancerJiliang Zhang, Shaojuan Zhang, Yang Liu, et al.
Biomaterials|April 29, 2015
A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1RXiaoxi Ling, Shaojuan Zhang, Pin Shao, et al.
Translational Oncology|July 14, 2018
Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent ProbeXiaoxia Guo, Xiaoxi Ling, Fang Du, et al.
Inorganic Chemistry|March 10, 2021
Design of Functional Chiral Cyclen-Based Radiometal Chelators for TheranosticsLixiong Dai, Junhui Zhang, Carlos Tinlong Wong, et al.
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeShaojuan Zhang, Pin Shao, Xiaoxi Ling, et al.
Theranostics|June 23, 2017
<sup>177</sup>Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing MiceCindy J Choy, Xiaoxi Ling, Jonathan J Geruntho, et al.
Nature Communications|March 1, 2018
Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applicationsLixiong Dai, Chloe M Jones, Wesley Ting Kwok Chan, et al.
Nuclear Medicine and Biology|January 30, 2026
Development of an automated one-step radiolabeling procedure for a PSMA-targeted radiotherapeutic for prostate cancerMeltem Ocak, Kanishka Sikligar, Michael Pun, et al.
Molecular Imaging and Biology|July 20, 2019
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403Xiaoxi Ling, Joseph D Latoche, Cindy J Choy, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|September 29, 2020
Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma CellsJemianne B Jia, Xiaoxi Ling, Minzhi Xing, et al.
Photodiagnosis and Photodynamic Therapy|September 22, 2018
Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancerJiliang Zhang, Shaojuan Zhang, Yang Liu, et al.
Biomaterials|April 29, 2015
A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1RXiaoxi Ling, Shaojuan Zhang, Pin Shao, et al.
Translational Oncology|July 14, 2018
Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent ProbeXiaoxia Guo, Xiaoxi Ling, Fang Du, et al.
Inorganic Chemistry|March 10, 2021
Design of Functional Chiral Cyclen-Based Radiometal Chelators for TheranosticsLixiong Dai, Junhui Zhang, Carlos Tinlong Wong, et al.
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeShaojuan Zhang, Pin Shao, Xiaoxi Ling, et al.
Theranostics|June 23, 2017
<sup>177</sup>Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing MiceCindy J Choy, Xiaoxi Ling, Jonathan J Geruntho, et al.
Nature Communications|March 1, 2018
Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applicationsLixiong Dai, Chloe M Jones, Wesley Ting Kwok Chan, et al.
Nuclear Medicine and Biology|January 30, 2026
Development of an automated one-step radiolabeling procedure for a PSMA-targeted radiotherapeutic for prostate cancerMeltem Ocak, Kanishka Sikligar, Michael Pun, et al.
Molecular Imaging and Biology|July 20, 2019
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403Xiaoxi Ling, Joseph D Latoche, Cindy J Choy, et al.
Pageof 2